✦ LIBER ✦

Pharmacokinetics and pharmacodynamic biomarkers in early oncology drug development

✍ Scribed by Chris H. Takimoto

Book ID: 117660532
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 56 KB
Volume: 45
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(09)70080-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetic/Pharmacodynamic Modellin

Pharmacokinetic/Pharmacodynamic Modelling in Oncological Drug Development

✍ Mats O. Karlsson; Therese Anehall; Lena E. Friberg; Anja Henningsson; Charlotte 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB

Biomarkers in oncology drug development

✍ Darren R. Hodgson; Robin D. Whittaker; Athula Herath; Dereck Amakye; Glen Clack 📂 Article 📅 2008 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 303 KB

Pharmacokinetic/pharmacodynamic studies

Pharmacokinetic/pharmacodynamic studies in drug product development

✍ Bernd Meibohm; Hartmut Derendorf 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB

In the quest of ways for rationalizing and accelerating drug product development, integrated pharmacokinetic/pharmacodynamic (PK/PD) concepts provide a highly promising tool. PK/PD modeling concepts can be applied in all stages of preclinical and clinical drug development, and their bene®ts are mult

Circulating tumor cells as pharmacodynam

Circulating tumor cells as pharmacodynamic biomarker in early clinical oncological trials

✍ Lot A. Devriese; Emile E. Voest; Jos H. Beijnen; Jan H.M. Schellens 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 240 KB

Plasma Protein Biomarkers as Indicators

Plasma Protein Biomarkers as Indicators of Pharmacokinetics and Pharmacodynamics in the Development of Novel Cancer Drugs

✍ Kenneth D. Tew 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 33 KB

The use of pharmacokinetic and pharmacod

The use of pharmacokinetic and pharmacodynamic data in the assessment of drug safety in early drug development

✍ D. K. Walker 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB